Literature DB >> 4592906

Multivariate analysis of prognostic factors in the non-Hodgkin's malignant lymphomas.

C D Bloomfield, A Goldman, F Dick, R D Brunning, B J Kennedy.   

Abstract

Entities:  

Mesh：

Year:  1974        PMID： 4592906     DOI： 10.1002/1097-0142(197403)33:3<870::aid-cncr2820330337>3.0.co;2-6

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  7 in total

1.  [Significance of clinical and laboratory chemical parameters for the course and prognosis of non-Hodgkin's lymphomas].

Authors:  B Steinke; J Mau
Journal:  Klin Wochenschr       Date:  1986-05-15

2.  Comparison of combined and single-agent chemotherapy in non-Hodgkin's lymphoma of favourable histological type.

Authors:  T A Lister; M H Cullen; M E Beard; R L Brearley; J M Whitehouse; P F Wrigley; A G Stansfeld; S B Sutcliffe; J S Malpas; D Crowther
Journal:  Br Med J       Date:  1978-03-04

3.  [Morphology versus prognosis in renal cell carcinoma a statistical approach].

Authors:  K Kofler; E R Reichl; W Zischka-Konorsa
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1975-11-28

4.  Progress in the management of high risk non-Hodgkin's lymphomas. 10 years of experience of the 3rd Medical Department of Hanusch Hospital, Vienna.

Authors:  R Heinz; H Hanak; A Stacher
Journal:  Klin Wochenschr       Date:  1985-07-15

5.  CHOP-firstline treatment in NHL with unfavorable prognosis--evaluation of therapeutic response and factors influencing prognosis.

Authors:  R Heinz; E Neumann; P Aiginger; J Pont; J Schüller; G Walcher; H Hanak; T Radaszkiewicz; E Sinn; M Wirth
Journal:  Blut       Date:  1985-05

6.  A critical analysis of prognostic factors for survival in intermediate and high grade non-Hodgkin's lymphoma. Scotland and Newcastle Lymphoma Group Therapy Working Party.

Authors:  R L Hayward; R C Leonard; R J Prescott
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

7.  Prognostic factors in non-Hodgkin's lymphoma: the importance of symptomatic stage as an adjunct to the Kiel histopathological classification.

Authors:  R C Leonard; J Cuzick; I C MacLennan; R I Vanhegan; P H Mackie; C V McCormick
Journal:  Br J Cancer       Date:  1983-01       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.